{"chunk_id": "medquad__chunk_6524", "source": "medquad", "text": "usion. These may be used alone or to carry drugs, toxins, or radioactive material directly to cancer cells.      Bevacizumab is a monoclonal antibody that is being studied in the treatment of Kaposi sarcoma.    TKIs are targeted therapy drugs that block signals needed for tumors to grow.      Imatinib mesylate is a TKI being studied in the treatment of Kaposi sarcoma.\n                              \n                \n                    Patients may want to think about taking part in a clinical tr"}